eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2020
vol. 15
 
Share:
Share:
abstract:
Original paper

Clinical experience of use of 13C-breath tests in oesophagogastroduodenal diseases: selective questions

Vadim Shypulin
1
,
Volodimir Chernyavskyi
1
,
Tetyana Nechypurenko
1
,
Artyom Neverovskyi
1
,
Lesya Gvozdecka
1
,
Natallya Mikhn’ova
1

1.
Department of Internal Medicine No. 1, Bogomolets National Medical University, Kyiv, Ukraine
Gastroenterology Rev 2020; 15 (2): 126–130
Online publish date: 2019/12/01
View full text Get citation
 
PlumX metrics:
Introduction
Motility disorders can be an important factor in the occurrence of symptoms of of dyspepsia that consequently require evaluation of clinical significance of noninvasive diagnostic approaches when observing patients with functional dyspepsia (FD), gastroesophageal reflux disease (GERD), and Helicobacter pylori-associated diseases of the stomach and duodenum.

Aim
To determine the relationship between various motility disorders and to improve the diagnostics and treatment with the use of 13C-urea (UBT) and 13C-octanoic breath tests (OBT).

Material and methods
A total of 591 patients, aged 18–83 years, who underwent upper gastrointestinal endoscopy at our department were evaluated. Age, sex, and duration of symptoms of dyspepsia were recorded. UBT and OBT were examined in patients with dyspepsia, GERD, and H. pylori-associated diseases.

Results
Patients with dyspepsia syndrome had H. pylori infection in 70 ±1.3% of cases. The strategy of “test-and-treat” using UBT can be applied in 76.5% of cases of unexplained dyspepsia in the Ukrainian population. In patients with GERD, slowing down of the gastric emptying (GE) prevails (overall 79.7 ±4.4%), which is a reliable predictor of early relapse of GERD symptoms (OR = 4.9, 2.4–7.0). In the case of H. pylori-associated diseases, the slowing down of GE according to OBT data is a prognostic sign of the return of the symptoms of dyspepsia after successful eradication of H. pylori (OR = 2.1, 1.9–2.3). In H. pylori-associated diseases with a slow GE, recurrence of dyspeptic syndrome after H.pylori-eradication therapy is observed in 33.1% of cases; the appointment of prokinetics reduces this probability to 9.2% (p = 0.0074).

Conclusions
Investigations into the clinical use of new facilities of 13C-breath tests in gastroenterology are shown. The clinical efficacy of urea and octanoic breath tests in FD, GERD, and H. pylori-associated diseases was proven experimentally among patients of the Ukrainian population. New simplified diagnostic and treatment approaches were proposed for certain groups of patients with gastric dyspepsia syndrome, based on the results of the UBT and the OBT.

keywords:

13C-urea breath test, 13C-octanoic breath test, dyspepsia, chronic gastritis, gastroesophageal reflux disease, Helicobacter pylori-associated diseases

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.